BMC Cancer

BMC Cancer
Added Value of Preoperative Contrast-Enhanced Mammography in Staging of Malignant Breast Lesions

Researchers evaluate the added value of CEM in preoperative staging of breast cancer in a randomized study.

BMC Cancer
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients With Muscle-Invasive Bladder Cancer (EFFORT-MIBC)

Researchers work to stratify patients and guide further treatment decisions in order to improve the outcome of patients with primary MIBC.

BMC Cancer
Minimally Important Differences for the EORTC QLQ-C30 in Prostate Cancer Clinical Trials

This study estimates the MID for interpreting group-level change over time, both within a group and between groups, for the EORTC QLQ-C30 scores in patients with prostate cancer.

BMC Cancer
Metabolic Syndrome and its Component Traits Present Gender-Specific Association with Liver Cancer Risk

Researchers explore the gender-specific effect and potential role of non-linear associations between MetS components and liver cancer risk.

BMC Cancer
Phase II Feasibility Study of Adjuvant Chemotherapy with Docetaxel/Cisplatin/S-1 Followed by S-1 for Stage III Gastric Cancer

This phase II trial evaluates the feasibility, safety, and efficacy of postoperative adjuvant therapy with DCS following S-1 therapy in patients with stage IIIA, IIIB, and IIIC gastric cancer...

BMC Cancer
miR-17-5p Drives G2/M-Phase Accumulation by Directly Targeting CCNG2 and is Related to Recurrence of Head and Neck Squamous Cell Carcinoma

This study aims to clarify the role of miR-17-5p in the cell cycle process of HNSCC and the correlation with clinical characteristics of patients with HNSCC...

BMC Cancer
Effect of EPA on Hsp90 and GRα Protein Expression in Multiple Myeloma Drug-Resistant Cells

Scientists test the cytotoxic effects of EPA alone or EPA + Dexamethasone in MM.1R and investigate whether DHA can induce apoptosis and reverse acquired glucocorticoid resistance in MM.1R.

BMC Cancer
The Risk and Prognostic Factors for Brain Metastases in Esophageal Cancer Patients

Scientists summarize the incidence, the risk factors, and the prognostic factors of brain metastases in esophageal cancer patients using the SEER database. 

BMC Cancer
Application of CD54 in Diagnosing Bone Marrow Involvement by Using Flow Cytometry in Patients With Diffuse Large B-Cell Lymphoma

Investigators detected the expression CD54 on lymphoma cells in BM specimens from DLBCL patients...

BMC Cancer
Co-Expression and Prognosis Analyses of GLUT1–4 and RB1 in Breast Cancer

In this study, investigators analyze the co-expression of GLUT1–4 and the influence of GLUT1–4 gene expression on the prognosis of breast cancer.

BMC Cancer
Subscribe to BMC Cancer

source list reference

rgb(171, 222, 222)
200, 66, 245
rgb(195, 2, 230)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(242, 0, 137)
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
rgb(156, 242, 7)
rgb(224, 4, 129)
rgb(80, 147, 199)
rgb(5, 235, 235)
rgb(235, 190, 9)
rgb(209, 227, 11)
200, 66, 245
rgb(217, 7, 192)
rgb(2, 230, 230)